Position in NVO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,711,501
+$1,237,369 QoQ
Shares Held
155,415
+76.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital International, Inc./CA/ holds $919,638,265 across 11 Drug Manufacturers - General names. NVO ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,009,997 | $396,411,608 | |
| 2 | LLY |
ELI LILLY & Co
|
193,029 | $177,542,283 | |
| 3 | AMGN |
Amgen Inc
|
398,069 | $140,060,577 | |
| 4 | ABBV |
AbbVie Inc.
|
430,429 | $93,614,003 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
355,956 | $49,609,587 | |
| 6 | JNJ |
Johnson & Johnson
|
156,815 | $38,331,858 | |
| 7 | PFE |
Pfizer Inc
|
374,286 | $10,509,950 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
155,415 | $5,711,501 |
All Filings in NVO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,711,501 | 155,415 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,474,132 | 87,935 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $12,961,243 | 233,578 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,531,953 | 80,150 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,966,482 | 57,121 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,715,856 | 66,448 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,064,711 | 50,934 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,140,283 | 50,023 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,835,009 | 45,444 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,190,966 | 40,512 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,359,529 | 25,946 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,141,953 | 14,113 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $854,263 | 10,736 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $722,377 | 10,675 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $545,822 | 10,957 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $568,070 | 10,196 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $121,044 | 2,180 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $137,144 | 2,449 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $119,004 | 2,479 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $117,487 | 2,805 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $102,208 | 3,032 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $111,829 | 3,202 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $111,157 | 3,202 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $117,110 | 3,577 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $111,219 | 3,695 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||